A Single-Center, Open-Label, Exploratory Study of the Volumizing Effect of SCULPTRA Measured by Three Dimensional Digital Surface Imaging

Inclusion Criteria: * Subjects must sign a statement of informed consent. * Subjects must be 18-75 years of age, of any race or gender. * Female patients of childbearing potential must have a negative urine pregnancy test prior to the first treatment with the product and must use an acceptable form of birth control throughout the study (e.g., oral/systemic contraceptives, an intrauterine device (IUD) or Norplant starting at least 28 days prior to study entry and throughout the study). * Subjects must display signs of facial contour deficiencies in the area of the nasolabial folds \[nasolabial fold scores greater than or equal to 2 (bilaterally) on the Dermik Nasolabial Photo-numeric Scale. * Subjects must be a suitable candidate for SCULPTRA treatment. * Subjects must be able to understand the requirements of the study and be willing to comply with the study requirements Exclusion Criteria: * Subjects with an allergy to any of the constituents of the product. * Subjects with a known history of keloids or bleeding disorders. * Subjects of childbearing potential who are pregnant, or plan to become pregnant within the study timeframe, or who are nursing. * Subjects with significant facial hair (e.g. mustaches, beards, etc.) * Subjects with an active inflammatory process or infection in the area to be treated (skin eruptions such as cysts, pimples, rashes, cancerous/pre-cancerous lesions, or any other active skin disease in the treatment area). * Subjects who plan to undergo major facial surgery \[e.g., rhinoplasty (with or without implant), facelift, congenital defect repair, etc.\] during the course of the study. * Subjects who have used or plan to use exclusionary medications/treatments.